BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on Erwinase® 10.000 IU/vial, powder for solution for injection: Information on temporary shortages

Active substance: Crisantaspase

The company Jazz Pharmaceuticals Germany GmbH is circulating information on the fact that over a period of 4 to 5 weeks there will be temporary shortages as regards new orders of Erwinase®.

Download DHPC/Information letter , Download_VeroeffentlichtAm_EN PDF, 38KB, File is accessible